Fingerprint
Dive into the research topics of 'A phase II study of tipifarnib and gemcitabine in metastatic breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase II study of tipifarnib and gemcitabine in metastatic breast cancer
Clinton Yam, Rashmi K. Murthy, Vicente Valero, Janio Szklaruk, Girish S. Shroff, Carol J. Stalzer, Aman U. Buzdar, James L. Murray, Wei Yang, Gabriel N. Hortobagyi, Stacy L. Moulder, Banu Arun
Research output: Contribution to journal › Article › peer-review
18
Scopus
citations